Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

DOI: 10.1530/EJE-07-0148
European Journal of Endocrinology, Vol 157, suppl_1, S15-S26
Copyright © 2007 by European Society of Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walenkamp, M J E
Right arrow Articles by Wit, J M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walenkamp, M J E
Right arrow Articles by Wit, J M
ARTICLE

Genetic disorders in the GH–IGF-I axis in mouse and man

M J E Walenkamp and J M Wit

Department of Pediatrics J6-S, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands

(Correspondence should be addressed to M J E Walenkamp; Email: m.walenkamp{at}lumc.nl)

This paper was presented at the Ipsen symposium, ‘The evolving biology of growth and metabolism’, Lisbon, Portugal, 16–18 March 2007. Ipsen has supported the publication of these proceedings.

Abstract

Animal knockout experiments have offered the opportunity to study genes that play a role in growth and development. In the last few years, reports of patients with genetic defects in GH–IGF-I axis have greatly increased our knowledge of genetically determined causes of short stature. We will present the animal data and human reports of genetic disorders in the GH–IGF-I axis in order to describe the role of the GH–IGF-I axis in intrauterine and postnatal growth. In addition, the effects of the GH–IGF-I axis on the development and function of different organ systems such as brain, inner ear, eye, skeleton, glucose homeostasis, gonadal function, and immune system will be discussed. The number of patients with genetic defects in the GH–IGF-I axis is small, and a systematic diagnostic approach and selective genetic analysis in a patient with short stature are essential to identify more patients. Finally, the implications of a genetic defect in the GH–IGF-I axis for the patient and the therapeutic options will be discussed.




This article has been cited by other articles:


Home page
 Biol. Reprod.Home page
M. C. Satterfield, K. Hayashi, G. Song, S. G. Black, F. W. Bazer, and T. E. Spencer
Progesterone Regulates FGF10, MET, IGFBP1, and IGFBP3 in the Endometrium of the Ovine Uterus
Biol Reprod, December 1, 2008; 79(6): 1226 - 1236.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
A. K. Dilly and R. V. S. Rajala
Insulin Growth Factor 1 Receptor/PI3K/AKT Survival Pathway in Outer Segment Membranes of Rod Photoreceptors
Invest. Ophthalmol. Vis. Sci., November 1, 2008; 49(11): 4765 - 4773.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
H A van Duyvenvoorde, M J E Kempers, T. B Twickler, J van Doorn, W J Gerver, C Noordam, M Losekoot, M Karperien, J M Wit, and A R M M Hermus
Homozygous and heterozygous expression of a novel mutation of the acid-labile subunit
Eur. J. Endocrinol., August 1, 2008; 159(2): 113 - 120.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 European Society of Endocrinology.